These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 22475624)
1. IgM-monoclonal gammopathy neuropathy and tremor: a first epidemiologic case control study. Ahlskog MC; Kumar N; Mauermann ML; Klein CJ Parkinsonism Relat Disord; 2012 Jul; 18(6):748-52. PubMed ID: 22475624 [TBL] [Abstract][Full Text] [Related]
2. Neuropathy associated with monoclonal gammopathies of undetermined significance. Gosselin S; Kyle RA; Dyck PJ Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848 [TBL] [Abstract][Full Text] [Related]
10. IgM MGUS associated with anti-MAG neuropathy: a single institution experience. Talamo G; Mir MA; Pandey MK; Sivik JK; Raheja D Ann Hematol; 2015 Jun; 94(6):1011-6. PubMed ID: 25572169 [TBL] [Abstract][Full Text] [Related]
11. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy]. Saito T Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697 [TBL] [Abstract][Full Text] [Related]
12. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Suarez GA; Kelly JJ Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128 [TBL] [Abstract][Full Text] [Related]
13. IgM MGUS anti myelin-associated glycoprotein neuropathy can rarely express as a predominantly distal motor neuropathy. Galassi G; Tondelli M Muscle Nerve; 2016 May; 53(5):827-8. PubMed ID: 26690862 [No Abstract] [Full Text] [Related]
14. Analyzing Relationship Between Monoclonal Gammopathy of Undetermined Significance (MGUS) with Different Types of Neuropathy: An Observational Study. Nabi S; Kahlon P; Bozorgnia F; Arshad A; Saleem A; Kuriakose P Indian J Hematol Blood Transfus; 2016 Jun; 32(2):186-92. PubMed ID: 27065581 [TBL] [Abstract][Full Text] [Related]
16. [Successful treatment with rituximab in two cases of IgM-monoclonal gammopathy of undetermined significance (MGUS) neuropathy]. Koike M; Sugimoto K; Tusui M; Yahata Y Rinsho Ketsueki; 2012 Apr; 53(4):450-4. PubMed ID: 22687979 [TBL] [Abstract][Full Text] [Related]
17. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients. Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065 [TBL] [Abstract][Full Text] [Related]
18. Quality of life in patients with polyneuropathy associated with different types of monoclonal gammopathy of undetermined significance. Opalic M; Peric S; Palibrk A; Bozovic I; Bjelica B; Stevic Z; Basta I Acta Neurol Belg; 2020 Oct; 120(5):1133-1138. PubMed ID: 31201672 [TBL] [Abstract][Full Text] [Related]
19. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience. Matà S; Torricelli S; Barilaro A; Grippo A; Forleo P; Del Mastio M; Sorbi S J Neurol Sci; 2021 Apr; 423():117335. PubMed ID: 33647732 [TBL] [Abstract][Full Text] [Related]
20. Revisiting the spectrum of IgM-related neuropathies in a large cohort of IgM monoclonal gammopathy. Bardel B; Molinier-Frenkel V; Le Bras F; Ayache SS; Nordine T; Lefaucheur JP; Planté-Bordeneuve V J Neurol; 2022 Sep; 269(9):4955-4960. PubMed ID: 35505107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]